1. A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma. Issue 1 (31st October 2022) Authors: Carlo‐Stella, Carmelo; Zinzani, Pier Luigi; Sureda, Anna; Araújo, Luis; Casasnovas, Olivier; Carpio, Cecilia; Yeh, Su‐Peng; Bouabdallah, Krimo; Cartron, Guillaume; Kim, Won Seog; Cordoba, Raul; Koh, Youngil; Re, Alessandro; Alves, Daniela; Chamuleau, Martine; Le Gouill, Steven; López‐Guillermo, A... Journal: Hematological oncology Issue: Volume 41:Issue 1(2023) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗